1. Home
  2. BMEA vs PLCE Comparison

BMEA vs PLCE Comparison

Compare BMEA & PLCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMEA
  • PLCE
  • Stock Information
  • Founded
  • BMEA 2017
  • PLCE 1969
  • Country
  • BMEA United States
  • PLCE United States
  • Employees
  • BMEA N/A
  • PLCE N/A
  • Industry
  • BMEA Biotechnology: Pharmaceutical Preparations
  • PLCE Clothing/Shoe/Accessory Stores
  • Sector
  • BMEA Health Care
  • PLCE Consumer Discretionary
  • Exchange
  • BMEA Nasdaq
  • PLCE Nasdaq
  • Market Cap
  • BMEA 145.0M
  • PLCE 134.0M
  • IPO Year
  • BMEA 2021
  • PLCE 1997
  • Fundamental
  • Price
  • BMEA $4.25
  • PLCE $10.13
  • Analyst Decision
  • BMEA Buy
  • PLCE Hold
  • Analyst Count
  • BMEA 13
  • PLCE 3
  • Target Price
  • BMEA $27.92
  • PLCE $11.00
  • AVG Volume (30 Days)
  • BMEA 831.0K
  • PLCE 318.6K
  • Earning Date
  • BMEA 10-29-2024
  • PLCE 12-03-2024
  • Dividend Yield
  • BMEA N/A
  • PLCE N/A
  • EPS Growth
  • BMEA N/A
  • PLCE N/A
  • EPS
  • BMEA N/A
  • PLCE N/A
  • Revenue
  • BMEA N/A
  • PLCE $1,432,740,000.00
  • Revenue This Year
  • BMEA N/A
  • PLCE N/A
  • Revenue Next Year
  • BMEA N/A
  • PLCE N/A
  • P/E Ratio
  • BMEA N/A
  • PLCE N/A
  • Revenue Growth
  • BMEA N/A
  • PLCE N/A
  • 52 Week Low
  • BMEA $3.61
  • PLCE $4.77
  • 52 Week High
  • BMEA $20.21
  • PLCE $38.03
  • Technical
  • Relative Strength Index (RSI)
  • BMEA 42.32
  • PLCE 39.49
  • Support Level
  • BMEA $3.78
  • PLCE $9.58
  • Resistance Level
  • BMEA $4.29
  • PLCE $10.99
  • Average True Range (ATR)
  • BMEA 0.30
  • PLCE 0.65
  • MACD
  • BMEA 0.15
  • PLCE 0.09
  • Stochastic Oscillator
  • BMEA 89.71
  • PLCE 31.25

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

About PLCE Children's Place Inc. (The)

Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It design, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names.

Share on Social Networks: